Successful treatment of bullous pemphigoid with dupilumab: a case and brief review of the literature

Bullous pemphigoid is an autoimmune skin disease that results in formation of pruritic blisters. Most cases are treated with a combination of systemic and topical corticosteroids as well as other immunomodulatory drugs. Dupilumab is a fully human monoclonal antibody that acts as an antagonist agains...

Full description

Saved in:
Bibliographic Details
Published inDermatology online journal Vol. 27; no. 4
Main Authors Saleh, Maleck, Reedy, Matthew, Torok, Helen, Weaver, Joshua
Format Journal Article
LanguageEnglish
Published United States University of California Digital Library - eScholarship 2021
Subjects
Autoimmune diseases
Dermatology
Eczema
Monoclonal antibodies
Skin diseases
Online AccessGet full text

Cover

More Information
Summary:Bullous pemphigoid is an autoimmune skin disease that results in formation of pruritic blisters. Most cases are treated with a combination of systemic and topical corticosteroids as well as other immunomodulatory drugs. Dupilumab is a fully human monoclonal antibody that acts as an antagonist against IL4Ra traditionally used in the treatment of atopic dermatitis. We present an 80-year-old man with moderate to severe bullous pemphigoid successfully treated with dupilumab.
Bibliography:ObjectType-Case Study-3
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Review-1
ObjectType-Feature-5
ObjectType-Report-2
ObjectType-Article-4
ISSN:1087-2108
1087-2108
DOI:10.5070/D3274053155